What Is a 5-Panel Drug Test? When and Why Employers Use It

You're building out your drug testing program, and you keep seeing the same term everywhere: the 5-panel drug test. Maybe you're launching testing for the first time, or maybe you inherited a program that hasn't been reviewed in years and you're wondering whether it still meets current requirements. Either way, you need a clear answer to a straightforward question: what is a 5-panel drug test, what does it screen for, and is it the right fit for your organization?

Disclaimer: This content is provided for informational purposes only and should not be construed as legal advice. Employers should consult qualified counsel for their specific situation.

The standard five-panel drug screen remains the most commonly ordered workplace drug test in the United States, and for good reason. But"common" doesn't mean "one-size-fits-all," and the compliance environment around drug testing has shifted considerably in recent years. Here's what HR professionals need to know.

Key Takeaways

• A 5-panel drug test screens for five categories (each called a "panel") of commonly abused substances: marijuana (THC), cocaine, opiates, amphetamines, and phencyclidine (PCP).
• It is the testing standard mandated by the Department of Transportation for safety-sensitive positions and the most widely used panel for general workplace screening.
• Urine remains the most common specimen type for a standard 5-panel drug test, though hair and oral fluid testing are also available depending on employer needs and state law.
• Legal compliance is not optional. Federal, state, and local laws govern when, how, and under what circumstances employers can test, and the rules vary widely.
• Employers who use a consistent, standardized testing program with proper chain-of-custody procedures reduce their exposure to legal challenges and improve the reliability of results.

Understanding the 5-Panel Drug Test

The 5-panel drug test has been a cornerstone of workplace drug screening since the federal government established its drug-free workplace framework in the late 1980s. It was designed to target the substances most commonly associated with workplace impairment, safety incidents, and productivity loss. Decades later, it remains the baseline for most employer drug testing programs, whether federally mandated or voluntary.

What Is a 5-Panel Drug Test?

A 5-panel drug test is a screening that analyzes a biological specimen for the presence of five specific categories of controlled substances. The term "panel" refers to each substance group being tested. So a 5-panel test checks for five substance groups, a 10-panel checks for ten, and so on.

Did You Know?

The federal government conducts millions of DOT-regulated drug tests each year, all of which use the 5-panel as the required standard. It also serves as the starting point for millions of additional non-regulated employer programs annually.

• Marijuana (THC): The psychoactive compound in cannabis.

• Cocaine: Including crack cocaine and its metabolites.

• Opiates: Traditionally covering codeine, morphine, and heroin (6-acetylmorphine). Note that expanded opiate testing, which includes semi-synthetic opioids like oxycodone and hydrocodone, is now part of the DOT 5-panel but may not be included in all non-regulated panels unless specifically ordered.

• Amphetamines: Including amphetamine and methamphetamine, as well as MDMA (ecstasy), under the current DOT panel.

• Phencyclidine (PCP): A dissociative drug sometimes called "angel dust."

These five categories were selected because they represent the controlled substances most frequently associated with impairment in the workplace. The Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines on workplace testing established the original federal workplace testing guidelines that defined this panel.

What Does a 5-Panel Drug Test Include?

When people ask "what does a 5-panel drug test test for," they're usually asking about both the substances and the specimen type. The most common format is a 5-panel urine drug test. Urine testing is the only specimen type currently accepted for DOT-regulated testing, and it remains the default for most non-regulated programs as well.

Here's how the major specimen types compare for a 5-panel drug screening:

• Urine testing offers a detection window of roughly two to seven days for most substances (longer for chronic marijuana use). It is well-established, widely accepted by courts, and has clear federal guidelines for collection and chain of custody.
• Hair testing extends the detection window significantly, typically covering approximately 90 days of substance use history. However, hair testing is not permitted for DOT-regulated tests and is subject to restrictions in some states.
• Oral fluid (saliva) testing detects very recent use, generally within a window of a few hours up to 48 hours for most substances, though detection times vary by drug.

Each specimen type has trade-offs in detection window, collection convenience, and legal acceptance. The right choice depends on your testing goals, your industry, and the jurisdictions where you operate.

The Importance of 5-Panel Drug Tests for Employers

Drug testing isn't about catching people. It's about building a workplace where everyone goes home safe at the end of the day. Drug use in the workplace contributes to higher recruiting costs, training expenses, workers' compensation claims, and lost productivity. A well-run drug testing program is not a cost center; it's a risk management tool.

Pro Tip

Implementing regular drug testing at multiple touchpoints, including pre-employment, post-accident, reasonable suspicion, and random testing, can significantly reduce workplace accidents and associated liability. The key is consistency and clear policy communication.

Why Employers Use the 5-Panel Drug Test

Employers gravitate toward the standard 5-panel drug test for several practical reasons:

• Cost-effectiveness. The 5-panel is the most affordable panel option because it targets the most commonly abused substances without the added cost of testing for additional drug categories. For organizations with high-volume hiring, this matters.
• Regulatory alignment. For employers subject to DOT regulations, including those in transportation, aviation, pipeline, and maritime industries, the US Department of Transportation (DOT) 49 CFR Part 40 procedures are not optional. It is the federally mandated standard. Using the same panel across your entire workforce, regulated and non-regulated, can simplify program administration.
• Broad coverage of common substances. The five categories on this panel account for the vast majority of positive workplace drug tests.
• Established legal precedent. Because the 5-panel has been the federal standard for decades, there is extensive legal precedent supporting its use, which can be valuable if a testing result is ever challenged.

Some employers choose to go beyond the 5-panel by adding substances like benzodiazepines, barbiturates, or expanded opioids. The right panel depends on your industry, your risk profile, and the substances most prevalent in your workforce's geographic area.

Legal Considerations and Compliance

This is where things get complicated, and where HR professionals need to pay close attention.

At the federal level, DOT-regulated employers must follow 49 CFR Part 40, which specifies the exact procedures for the DOT 5-panel drug test, including specimen collection, laboratory analysis, Medical Review Officer review, and reporting. If you're a DOT-regulated employer, federal rules under 49 CFR Part 40 govern your testing program for safety-sensitive positions, even in states that have legalized marijuana. Consult qualified counsel to understand how federal and state requirements interact across your full workforce.

For non-regulated employers, the legal landscape is a patchwork. Key considerations include:

• Marijuana legalization. As of 2025, the National Conference of State Legislatures (NCSL) on state marijuana laws indicates that the majority of US states have legalized marijuana in some form, whether medical, recreational, or both. A growing number of states and cities have enacted laws restricting or prohibiting employers from testing for marijuana or from taking adverse action based on a positive marijuana test for non-safety-sensitive positions.

• • States and jurisdictions with specific protections for off-duty marijuana use include New York, California, Washington, and several others.

• State drug testing statutes. Some states, such as Florida and Ohio, have drug-free workplace programs that offer workers' compensation premium discounts to employers who follow specific testing protocols. Other states impose restrictions on when and how testing can occur.
• ADA considerations. The Americans with Disabilities Act does not protect current illegal drug use, but it does protect individuals who are in recovery or who are taking legally prescribed medications. The Medical Review Officer review is a critical safeguard here.

The bottom line: employers should have their drug testing policies reviewed by qualified legal counsel and update them regularly to reflect changes in the jurisdictions where they operate.

How Technology Is Improving 5-Panel Drug Test Programs

The drug testing industry has evolved considerably from the days of paper chain-of-custody forms and week-long turnaround times. Employers now have access to tools that make testing faster, more accurate, and more manageable at scale.

Enhancements in Testing Accuracy

Modern laboratory techniques have significantly improved the reliability of drug test results. Two-stage testing, where an initial immunoassay screen is followed by confirmatory testing using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), advanced lab methods that identify the exact chemical structure of a substance, has become the standard of care for laboratory-based testing.

This two-stage approach matters because initial screening tests, while effective, are not infallible. Confirmatory testing virtually eliminates false positives by identifying the exact molecular structure of the substance detected.

Additionally, laboratories have refined their cutoff levels, the concentration thresholds that determine whether a result is reported as positive or negative, to better distinguish between incidental exposure and actual substance use. SAMHSA periodically updates its recommended cutoff levels to reflect current science.

Impact on Test Efficiency

Speed matters in hiring. Every day a candidate waits for drug test results is a day they might accept another offer. Modern drug testing programs address this in several ways:

• Electronic chain of custody. Digital forms reduce errors, speed up processing, and create a cleaner audit trail compared to paper-based systems.
• Online result delivery. Employers and their designated representatives can access results through secure web portals as soon as they are finalized, rather than waiting for faxes or mail.
• ATS and HCM integration. Leading screening providers now offer direct integrations with applicant tracking systems and human capital management platforms, so drug test orders and results flow directly into the employer's existing workflow. AccuSourceHR's SourceDirect™ platform integration with major ATS and HCM systems, for example, connects with Workday, Greenhouse, BambooHR, iCIMS, UKG, and many others, keeping drug testing data connected to the rest of your hiring process.
• Rapid testing options. Point-of-care rapid tests can deliver preliminary results in minutes, which is particularly useful for post-accident and reasonable-suspicion testing scenarios where time is critical. However, rapid tests should always be backed by laboratory confirmation for any non-negative result.

Preparing for a 5-Panel Drug Test

Whether you're setting up a drug testing program from scratch or refining an existing one, preparation is the difference between a program that protects your organization and one that creates liability.

Steps for Employers

• Develop a written drug testing policy.** Your policy should clearly state the circumstances under which testing occurs (pre-employment, random, post-accident, reasonable suspicion, return-to-duty), the substances tested, the consequences of a positive result or refusal to test, and the employee's rights. Have this policy reviewed by legal counsel familiar with the laws in every state where you operate.

• Select the right panel for your needs.** The standard 5-panel drug test is appropriate for many employers, but consider whether your industry, risk profile, or state law warrants additional substances. Employers in healthcare, for instance, may want to include benzodiazepines and expanded opioids.

• Choose a PBSA-certified screening provider.** Not all drug testing providers are created equal. A provider certified by the Professional Background Screening Association demonstrates adherence to industry standards for accuracy, compliance, and data security. Learn more about AccuSourceHR's drug testing services to see how a certified provider supports a defensible program.

• Ensure proper collection procedures.** Use certified collection sites that follow established chain-of-custody protocols. For DOT testing, collectors must be trained and qualified under 49 CFR Part 40.
• Designate a Medical Review Officer.** An MRO is a licensed physician trained to review and interpret drug test results. The MRO contacts the donor to verify any legitimate medical explanations for a positive result before reporting it to the employer. This step is required for DOT testing and strongly recommended for all programs.

Pro Tip

Choose a testing provider that offers digital integration with your existing HR technology stack. Managing drug test orders, results, and compliance documentation through a single connected platform reduces administrative burden and minimizes the risk of errors.

What Employees Should Know

Transparency builds trust. Employees and candidates should understand the following about the 5-panel drug test process:

• Advance notice. Most non-random testing scenarios come with advance notice. Employees should receive a copy of the company's drug testing policy, ideally during onboarding and whenever the policy is updated.
• The collection process. For a 5-panel urine drug test, the donor provides a specimen at a certified collection site under controlled conditions. The collector verifies the specimen's temperature and integrity, and the donor initials the chain-of-custody form.
• Their rights. If a test comes back positive, the MRO will contact the donor before reporting the result to the employer. The donor has the opportunity to provide documentation of a valid prescription or other medical explanation. In many jurisdictions, employees also have the right to request a retest of the original specimen at a different certified laboratory.
• Confidentiality. Drug test results are confidential medical information. They should be shared only with individuals who have a legitimate need to know, such as the designated employer representative and the MRO.

Consequences of Not Using Standardized Testing

Some employers take a casual approach to drug testing: inconsistent policies, point-of-care tests without laboratory confirmation, or testing procedures that vary from location to location. This approach invites litigation and poses a genuine safety risk.

Legal exposure. An employer who tests inconsistently, applying different standards to different employees or locations, opens the door to discrimination claims. If your policy states you test all candidates for a particular role but only some are actually tested, the inconsistency creates significant legal exposure.

Unreliable results. Without laboratory confirmation, preliminary positive results may be inaccurate, leading to wrongful adverse employment decisions. Specimen integrity is also a growing concern; without proper collection protocols and specimen validity testing, tampering attempts may go undetected.

Safety incidents. The entire point of workplace drug testing is to reduce the risk of impairment-related accidents. An inadequate testing program provides a false sense of security while leaving the underlying risk unaddressed.

Workers' compensation and insurance implications. In states with drug-free workplace programs, failure to follow standardized testing procedures can disqualify an employer from premium discounts or limit the employer's ability to deny a workers' compensation claim related to substance use.

A standardized drug testing program delivers consistent, defensible results across your entire organization. Standardization means uniform policy application, SAMHSA-certified laboratories, consistent chain of custody, MRO review for every positive, and regular policy audits at least annually.

Actionable Steps for HR Professionals

• Audit your current drug testing policy. Review your written policy against the laws in every state and locality where you have employees. Pay particular attention to marijuana-related restrictions, which have changed rapidly in recent years. If your policy hasn't been updated in the last 12 months, it's overdue.

• Confirm your panel selection matches your risk profile. The standard 5-panel drug test is a strong baseline, but evaluate whether your industry or workforce demographics warrant expanded testing. Discuss options with your screening provider and legal counsel.

• Verify your provider's credentials. Is your drug testing provider PBSA-certified? Do they use SAMHSA-certified laboratories? Do they provide MRO services? These are not nice-to-haves. They are the minimum standards for a defensible program.

• Train your supervisors. Supervisors are your first line of defense for reasonable-suspicion testing. They need documented training on how to recognize signs of impairment and how to follow your company's procedures for initiating a test. Without training, reasonable-suspicion determinations are vulnerable to legal challenge.

• Integrate drug testing into your HR technology workflow. If your drug test orders and results still live in a separate system from your applicant tracking or onboarding platform, you're creating unnecessary friction and risk. Look for a provider whose platform connects directly with your existing tools.

• Communicate transparently with candidates and employees. Make your drug testing policy easily accessible. Explain the process, the substances tested, and the employee's rights. Transparency reduces anxiety and builds trust in the fairness of your program.

• Review your program annually. Drug testing compliance is not a set-it-and-forget-it proposition. Schedule an annual review with your screening provider and legal counsel to ensure your program reflects current law and best practices.

The AccuSourceHR Advantage

Managing the complexities of workplace drug testing, from panel selection and multi-state compliance to result turnaround, requires a screening partner that understands both the science and the regulations. At AccuSourceHR, our in-house counsel-led compliance team stays on top of the shifting legal environment so you don't have to track every state marijuana law or DOT rule change on your own. Our 100% US-based support team, FCRA-certified through the PBSA, answers calls live and resolves issues quickly because we know that in hiring, every hour counts.

Whether you're setting up a 5-panel drug testing program for the first time or looking to modernize an existing one, we'd welcome the conversation.

What's the biggest drug testing compliance challenge you're facing right now? Is it marijuana legalization, multi-state policy management, or something else entirely? We welcome your questions and feedback. Share your thoughts by commenting on this article on LinkedIn, or reach out to our team directly to talk through your program needs.